0000950170-24-091964.txt : 20240806 0000950170-24-091964.hdr.sgml : 20240806 20240806170003 ACCESSION NUMBER: 0000950170-24-091964 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240802 FILED AS OF DATE: 20240806 DATE AS OF CHANGE: 20240806 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sullivan Lynne Marie CENTRAL INDEX KEY: 0001727640 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38470 FILM NUMBER: 241180266 MAIL ADDRESS: STREET 1: C/O SOLID BIOSCIENCES, LLC STREET 2: 141 PORTLAND STREET, FIFTH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unity Biotechnology, Inc. CENTRAL INDEX KEY: 0001463361 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 264726035 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 285 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 416-1192 MAIL ADDRESS: STREET 1: 285 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Cenexys, Inc. DATE OF NAME CHANGE: 20130703 FORMER COMPANY: FORMER CONFORMED NAME: Forge Inc DATE OF NAME CHANGE: 20090504 4 1 ownership.xml 4 X0508 4 2024-08-02 0001463361 Unity Biotechnology, Inc. UBX 0001727640 Sullivan Lynne Marie 285 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 false true false false CFO & Head of Corp. Dev. false Common Stock, $0.0001 par value 2024-08-02 4 S false 139 1.53 D 56061 D Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units. Includes Restricted Stock Units which vest over time measured from the grant date. Represents adjusted total that includes an aggregate of 23,515 shares purchased under the Unity Biotechnology, Inc. 2018 Employee Stock Purchase Plan on May 15, 2023 and May 15, 2024 in transactions exempt from reporting pursuant to Rule 16b-3(c). /s/ Alexander Nguyen, Attorney-in-Fact for Lynne Sullivan 2024-08-06